# Hey Pain, Sad to See You Go! (A Review of Adjuvant Pain Medications) | Pain Pod

Page: https://stenobird.com/podcast/pharmacy-podcast-network-945715/hey-pain-sad-to-see-you-go-a-review-of-adjuvant-pain-medications-pain-pod
Text version: https://stenobird.com/podcast/pharmacy-podcast-network-945715/hey-pain-sad-to-see-you-go-a-review-of-adjuvant-pain-medications-pain-pod.md
Podcast: [Pharmacy Podcast Network](https://stenobird.com/podcast/pharmacy-podcast-network-945715)
Published: 2026-04-01T12:14:39+00:00
Episode link: https://pharmacypodcastnetwork.podbean.com/e/hey-pain-sad-to-see-you-go-a-review-of-adjuvant-pain-medications-pain-pod/
Audio file: https://mcdn.podbean.com/mf/web/pqvv87263yis4ucx/PainPod_Adjuvants.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/pharmacy-podcast-network-945715/episodes/hey-pain-sad-to-see-you-go-a-review-of-adjuvant-pain-medications-pain-pod
Duration seconds: 1610

## Resource

On this episode of the PAIN POD, Mark Pain Guy Garofoli chats through the complexities of adjuvant pain medications including antidepressant and other medications from other medical condition treatment plans that overlap in mechanism with pain. Join the discussion right here, right now, on the Pain Pod. Come one, come all, to the Pain Pod!!!

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/pharmacy-podcast-network-945715/episodes/hey-pain-sad-to-see-you-go-a-review-of-adjuvant-pain-medications-pain-pod/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/pharmacy-podcast-network-945715/hey-pain-sad-to-see-you-go-a-review-of-adjuvant-pain-medications-pain-pod.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.